The Bradyarrhythmias: Disorders of the Sinoatrial Node¶
Chapter 251 | Part 6: Cardiovascular System
KEY CLINICAL POINTS¶
- The sinoatrial (SA) node is the natural pacemaker of the heart, with intrinsic rate governed by autonomic tone and ion currents (e.g., funny current, calcium channels).
- Sinus node dysfunction (SND) includes reversible causes (e.g., hypothyroidism, sleep apnea) and irreversible conditions (e.g., fibrosis, ischemia), requiring permanent pacing in symptomatic cases.
- Diagnostic evaluation involves ECG, Holter monitoring, exercise testing, and imaging to exclude structural heart disease.
- Treatment algorithms prioritize eliminating reversible causes, temporary pacing for acute episodes, and permanent pacemaker implantation for symptomatic patients.
- Tachy-brady syndrome (alternating tachycardia and bradycardia) often requires addressing underlying arrhythmias and pacing.
1. DEFINITION & OVERVIEW¶
Bradyarrhythmias involving the SA node include sinus node dysfunction (SND), sinus arrest, and SA block. The SA node generates electrical impulses to regulate heart rate, with intrinsic rate ~100 beats/min in denervated hearts.
Table 251-1 Reversible Causes of Sinus Node Dysfunction¶
| Medical Conditions | Medications |
|---|---|
| Hypothyroidism | Beta-blockers |
| Sleep apnea | Calcium channel blockers |
| Hypoxia | Digoxin |
| Increased intracranial pressure | Amiodarone |
| Lyme disease | Ivabradine |
| Myocarditis | Opioids |
| COVID-19 | Phenytoin |
| Vagal reflex | SSRIs |
| Anesthetic drugs | Tricyclic antidepressants |
1.1 SA Node Physiology¶
SA node cells have unique ion channels (funny current, T/L-type calcium channels) enabling spontaneous depolarization. Autonomic tone (parasympathetic dominance in adults) modulates rate. Structural heterogeneity includes central nodal cells with fewer myofibrils and no intercalated disks.
1.2 Classification¶
SND is categorized into impulse formation disorders (e.g., sick sinus syndrome) and conduction defects (e.g., SA block). Tachy-brady syndrome involves alternating tachycardia (e.g., AF) and bradycardia/pauses.
2. EPIDEMIOLOGY¶
SND is most common in older adults due to age-related fibrosis and loss of pacemaker cells. Prevalence increases with age, with intrinsic heart rate declining 5–6 beats/min per decade. Reversible causes (e.g., hypothyroidism, sleep apnea) account for 20–30% of cases.
2.1 Risk Factors¶
Age >65 years, hypothyroidism, sleep apnea, autonomic dysfunction, and medications (e.g., beta-blockers, calcium channel blockers).
2.2 Demographics¶
Predominantly elderly; 80% of SND cases occur in patients >65 years. Women are more likely to have sinus node fibrosis.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
SND arises from impaired impulse formation (e.g., fibrosis, ischemia) or conduction (e.g., SA block). Autonomic imbalance (parasympathetic dominance) and drug toxicity (e.g., digoxin) contribute. Ischemia of the SA nodal artery (right coronary artery) can cause transient or permanent dysfunction.
3.1 Molecular Mechanisms¶
Slow calcium currents (Ca-L) and funny current (I_f) drive phase 4 depolarization. Parasympathetic stimulation (acetylcholine) inhibits I_f, reducing rate.
3.2 Structural Changes¶
Age-related fibrosis, loss of pacemaker cells, and fibrotic replacement of SA node tissue impair impulse generation and conduction.
4. CLINICAL FEATURES¶
Symptoms include fatigue, syncope, exercise intolerance, and dyspnea. ECG findings: sinus bradycardia (<50 bpm), sinus pauses (>2 seconds), and junctional/ventricular escape rhythms. Asymptomatic bradycardia during sleep is common but not typically treated.
4.1 Symptomatology¶
Fatigue, syncope, dizziness, and exercise intolerance. Severe cases may present with heart failure or cardiac arrest.
4.2 ECG Findings¶
Sinus bradycardia, sinus pauses, SA block (Mobitz I/II), and junctional escape rhythms. Prolonged sinus pauses (>3 seconds) suggest severe dysfunction.
5. DIFFERENTIAL DIAGNOSIS¶
Differentiate SND from reversible causes (e.g., hypothyroidism, sleep apnea), medications, and other arrhythmias (e.g., AV block, atrial fibrillation). Exclude structural heart disease and infiltrative cardiomyopathies.
5.1 Reversible Causes¶
Hypothyroidism, sleep apnea, hypoxia, and drug toxicity (e.g., beta-blockers, digoxin).
5.2 Other Arrhythmias¶
AV block, atrial fibrillation, and ventricular pacing artifacts. Tachy-brady syndrome requires evaluation of underlying tachycardia.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis involves ECG, Holter monitoring, ambulatory telemetry, and exercise testing. Transthoracic echocardiography and advanced imaging (e.g., cardiac MRI) assess structural heart disease. Pharmacologic blockade (propranolol/atropine) evaluates intrinsic rate.
Table 251-2 Indications for Permanent Pacing in SND¶
| Indications |
|---|
| Symptomatic sinus bradycardia with no alternative treatment |
| Tachy-brady syndrome with symptomatic bradycardia |
| Symptomatic chronotropic incompetence |
| Reversible causes unresponsive to treatment |
| Asymptomatic SND with high-risk features (e.g., prolonged pauses) |
6.1 Diagnostic Tests¶
Baseline ECG, Holter monitoring, ambulatory telemetry, and exercise stress testing. Pharmacologic challenge with propranolol/atropine to assess intrinsic rate.
6.2 Imaging¶
Transthoracic echocardiography to exclude structural disease. Cardiac MRI for infiltrative cardiomyopathies (e.g., amyloidosis).
7. MANAGEMENT & TREATMENT¶
Management prioritizes eliminating reversible causes, temporary pacing for acute episodes, and permanent pacing for symptomatic patients. Pharmacologic agents (e.g., theophylline) may be trialed before pacing.
7.1 Temporary Pacing¶
Used for acute episodes (e.g., tachy-brady syndrome, SA block). Transvenous or epicardial pacing may be required in complex cases.
7.2 Permanent Pacing¶
Indicated for symptomatic patients with irreversible SND. Dual-chamber pacemakers are preferred to preserve atrioventricular synchrony.
7.3 Pharmacologic Therapy¶
Theophylline or beta-agonists may transiently improve rate in asymptomatic patients. Avoid medications causing bradycardia (e.g., digoxin).
8. PROGNOSIS & COMPLICATIONS¶
Asymptomatic SND is generally benign, but severe cases may lead to syncope, heart failure, or sudden cardiac death. Complications include pacemaker malfunction, lead complications, and drug interactions.
8.1 Prognostic Factors¶
Severity of bradycardia, presence of pauses, and underlying structural disease. Asymptomatic patients with isolated bradycardia have excellent prognosis.
8.2 Complications¶
Pacemaker infection, lead dislodgement, and inappropriate pacing. Drug-induced bradycardia may occur with antiarrhythmics or opioids.
9. SPECIAL CONSIDERATIONS¶
In pregnancy, pacemaker implantation is safe but requires careful timing. Elderly patients may have age-related fibrosis, requiring careful evaluation. Heart transplant recipients often have denervated hearts with intrinsic rates ~90–110 bpm.
9.1 Pregnancy¶
Pacemaker implantation is safe but requires avoiding radiation and certain medications. Monitor for fetal bradycardia.
10. KEY POINTS & CLINICAL PEARLS¶
- SA node dysfunction is common in elderly patients with age-related fibrosis. 2. Reversible causes (e.g., hypothyroidism, sleep apnea) must be excluded before pacing. 3. Permanent pacing is indicated for symptomatic patients with irreversible SND. 4. Tachy-brady syndrome requires addressing underlying tachycardia. 5. Theophylline may be trialed before pacing in equivocal cases.